NanoLogix and Welch Foods Inc. Sign Agreement for Hydrogen Bioreactor

Oct 18, 2005, 01:00 ET from NanoLogix, Inc.

    SHARON, Pa., Oct. 18 /PRNewswire-FirstCall/ -- NanoLogix, Inc.
 (Pink Sheets:   NNLX), a nanobiotechnology company moving rapidly towards the
 commercialization of its proprietary technologies for hydrogen generation
 systems, announced today that it has signed an agreement to install a
 NanoLogix hydrogen generation system using Welch Food's waste organic matter.
 The NanoLogix methodology for hydrogen production is being developed for the
 limitless production of hydrogen from organic containing waste waters.  Once
 successfully accomplished, this has the potentiality for solving the world
 energy crisis through the limitless production of hydrogen from any waste
 organic materials, such as sewer water, ground up garbage, etc.  NanoLogix has
 assembled a distinguished team of scientists and university professors to work
 on this exciting project.
     The NanoLogix reactor will utilize multiple proprietary methodologies for
 synergistically creating a hydrogen bioreactor.  The hydrogen production
 method will utilize organic waste from Welch Food's waste stream.
     "We are clearly excited with the opportunity to demonstrate conclusively
 that the production of hydrogen is efficient, inexpensive and can meet the
 increasing demand within the marketplace, both industrial and commercial,"
 stated David McClelland, President of NanoLogix, Inc.
     About NanoLogix
     NanoLogix, Inc. is a technology application innovator of
 biogas products and services designed to assist in worldwide energy
 independence and reduce pollution from renewable, environmentally-friendly
 energy sources.  NanoLogix had also previously engaged in the research and
 development of diagnostic test kits designed to be used for the rapid
 identification of infectious human diseases.  The Company's patents span the
 identification and antibiotic sensitivity testing of 34 disease-producing
 bacteria, including M. tuberculosis (TB), Mycobacterium avium-intracellulare
 (MAI), pseudomonas, and nocardia.  These bacteria are cited as prominent
 causes of morbidity and mortality in patients with cancer, cystic fibrosis,
 and AIDS.  Additionally, NanoLogix owns a patent for the nontoxic induction of
 apoptosis in cancer cells utilizing hydrophobic hydrocarbons.  Apoptosis is a
 method for inducing a genetically based induction of "cell suicide" in cells.
     About Welch's
     Welch's is the world's leading marketer of Concord and Niagara grape-based
 products, including grape juice and jelly. The company produces a variety of
 other fruit-based products, including 100% juices, juice cocktails, and drinks
 in the following forms: single serve, bottled, refrigerated, and frozen and
 shelf-stable concentrates. In addition, Welch's produces a number of fruit
 spread products under both the Welch's and BAMA brand names. Welch's web site
 can be found at
     This press release contains statements, which may constitute "forward-
 looking statements" within the meaning of the Securities Act of 1933 and the
 Securities Exchange Act of 1934, as amended by the Private Securities
 Litigation Reform Act of 1995. Those statements include statements regarding
 the intent, belief or current expectations of NanoLogix, Inc., and members of
 its management as well as the assumptions on which such statements are based.
 Prospective investors are cautioned that any such forward-looking statements
 are not guarantees of future performance and involve risks and uncertainties,
 and that actual results may differ materially from those contemplated by such
 forward-looking statements. Important factors currently known to management
 that could cause actual results to differ materially from those in forward-
 statements include fluctuation of operating results, the ability to compete
 successfully and the ability to complete before-mentioned transactions. The
 company undertakes no obligation to update or revise forward-looking
 statements to reflect changed assumptions, the occurrence of unanticipated
 events or changes to future operating results.

SOURCE NanoLogix, Inc.